Frameworks for Digital Advertising
Standards in Medicine.

India · Advertising framework

Print advertising and advertorials for digital health products in India

General market orientation, not campaign clearance. Research scope and dates

Product and service rules

Use the MDR classification for the exact intended purpose

Regulator guidance

CDSCO’s device framework includes medical-purpose software and diagnostic products. Determine the applicable classification, licence or other requirements before advertising clinical functions. The current CDSCO index includes device-software guidance; a generic wellness label does not decide whether a diagnostic function is regulated.

Sources: CDSCO Medical Devices and Diagnostics

Channel rules

Check the complete consumer-facing message

Regulator guidance

CCPA guidance addresses unsubstantiated claims, exaggerated promises and misleading advertisements and endorsements. Review the complete representation and its evidence, including claims made by an endorser. Disclosure or a disclaimer is not a substitute for the substantive conditions of a lawful advertisement.

Sources: Prevention of Misleading Advertisements and Endorsements, 2022

Separate enactment from commencement

Legal requirement — paraphrased

As of 25 October 2026, do not describe the entire DPDP consent and data-fiduciary regime as operational. The Act notification commences institutional provisions on publication, section 6(9) and section 27(1)(d) after one year, and principal processing, consent, rights and duty provisions after eighteen months.

Rules 1, 2 and 17–21 commence on publication; rule 4 after one year; rules 3, 5–16, 22 and 23 after eighteen months. Read these periods with the December 2025 corrigendum and record the applicable date for the campaign. Phasing does not itself remove other applicable privacy, confidentiality or telecom obligations.

Sources: DPDP Act commencement GSR 843(E); DPDP Rules 2025; DPDP Rules corrigendum December 2025

Review at final printed size

Editorial recommendation

Approve the advertorial label, full layout and legibility at actual size. Check what must appear in the advertisement itself before moving details behind a QR code.

Campaign workflow

Digital Health Products: prepare the review

Editorial recommendation

Classify each software function separately: lifestyle, medical software or delivery of care. Link accuracy and clinical outcome claims to the advertised software version and population. Review tracking and marketing data flows separately from permission to provide care.

Keep a traceable campaign decision

Editorial recommendation

Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.

Pre-publication checklist

  • Classify each software function separately: lifestyle, medical software or delivery of care.
  • Link accuracy and clinical outcome claims to the advertised software version and population.
  • Review tracking and marketing data flows separately from permission to provide care.
  • Record product or provider eligibility before approving claims.
  • Archive the final creative and its evidence, permissions and review decisions.
  • Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.

Scope and unresolved questions

  • Dental provisions and DPDP commencement phases have been added; the current NMC index points to the 2023 abeyance notification restoring the 2002 regime. State clinical establishment and pharmacy rules, AYUSH conduct, current Drugs Rules schedules and later FSSAI claim amendments remain incompletely verified. Check later Gazette amendments and actual product/registration details.
  • This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates

A digital-health offer promoted in print campaigns in India may combine a lifestyle function, medical software and a clinical service. Identify each advertised function and software version, then review clinical claims and the use of personal data separately.

Printed advertisements must work at their final physical size. Review the advertorial label, required information, images and multipage layout together, including what stays on the page when a QR code points readers elsewhere.

Sources checked 2026-10-24 · Editorial research · Legal review pending

General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.

Coverage: National baseline and category-specific review routes; not an exhaustive compliance opinion

How to use this national baseline

Editorial overview

This framework combines researched national rules with editorial review steps. Central advertising and health-product baseline; state licensing and profession-specific conditions need local review. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.

The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.

Your next step: choose a local partner

Use this framework to brief qualified local legal and regulatory specialists. Ask them to verify current requirements and assess your specific product, service and campaign before acting.

Sources

  1. CDSCO Medical Devices and Diagnostics

    CDSCO · regulator guidance · checked 2026-10-24

    Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.

  2. Prevention of Misleading Advertisements and Endorsements, 2022

    Central Consumer Protection Authority / Press Information Bureau · regulator guidance · checked 2026-10-24

    Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.

  3. DPDP Act commencement GSR 843(E)

    MeitY / Gazette of India · legislation · checked 2026-10-25

    Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.

  4. DPDP Rules 2025

    MeitY / Gazette of India · legislation · checked 2026-10-25

    Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.

  5. DPDP Rules corrigendum December 2025

    MeitY / Gazette of India · legislation · checked 2026-10-25

    Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.

From framework to action

Local expertise in India

Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in India.

Medical & health marketing

No partners listed in this category yet.

Marketing & sales advisory

No partners listed in this category yet.

Business & project coordination

No partners listed in this category yet.

Browse partners in India

Join the local partner directory

Would you like your company to be listed?

Talk to us about the terms of a listing. Leave your details and we will get in touch.

Publicity@fdasm.com

Contact details for a partner listing enquiry

We use your details to respond to your enquiry and discuss a listing. Submitting the form does not automatically add your company to the directory. Read our Privacy & cookies policy. Privacy contact: Publicity@fdasm.com.